Rethinking 'Stable': The Case for Measurement-Based Care in Schizophrenia

In "Rethinking 'Stable': The Case for Measurement-Based Care in Schizophrenia," our experts question the standard definition of a stable patient.

Dr. Jackson asks Dr. Hunter how often unresolved symptom burden goes unnoticed in patients labeled clinically stable, and what tools uncover deficits across all three symptom domains. Dr. Hunter argues the field needs measurement-driven care, since patients and families will report feeling better even while carrying significant ongoing burden. Without validated scales like the PANSS or BPRS, a rushed fifteen-minute visit, common in community mental health, misses functionality- and life-satisfaction-limiting symptoms. He notes clinicians routinely set concrete goals with depression, anxiety, and ADHD patients but rarely do so in schizophrenia, largely out of fear of destabilizing a fragile patient. Dr. Jackson extends the point, comparing a 22-year-old stroke patient who receives intensive rehabilitation to a same-age schizophrenia patient discharged from the hospital with no comparable push toward functional recovery.

Turning to Dr. Alva, Dr. Jackson presents a patient adherent and stable for four years despite ongoing symptoms, weight gain, and mild tardive dyskinesia, asking how to define real treatment success. Dr. Alva echoes the call for measurement-based care and questions how adherent a patient truly is, citing this as a reason he favors long-acting injectables for better oversight of medication use. He stresses balancing efficacy against side-effect burden, prioritizing patient education on hydration, nutrition, and activity, and setting realistic but genuinely aspirational goals. Positive symptoms like hallucinations and delusions can stall progress, he explains, but negative and cognitive symptoms are often the larger barrier to independence. Spencer Simon adds that clinicians must shepherd frightened patients and caregivers, building trust that allows them to embrace hope and accept a more ambitious treatment paradigm beyond simply avoiding hospitalization.

The next episode, "Assessing the Standard of Care in Schizophrenia," surveys today's treatment landscape, from long-acting injectables to combination therapy.